Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Dublin, March 10, 2026 (GLOBE NEWSWIRE) -- The "Hydase Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering. ...
-
Dublin, March 10, 2026 (GLOBE NEWSWIRE) -- The "Hylenex Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering. ...
-
Opus Genetics Announces Financial Results for Full Year 2025 and Provides Corporate Update
-
PORTLAND, Ore., March 10, 2026 (GLOBE NEWSWIRE) -- EVAA.AI, part of the MaximEyes AI suite by First Insight, announced today at Vision Expo 2026 (Booth 2317) a major expansion of its AI-powered...
-
Austin, TX, USA, March 10, 2026 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Viral Vaccine Cell Culture Media Market Size, Trends and Insights By Cell...
-
2026 consumer research report examining VisiFlora's 22-ingredient gut-eye axis formula, ingredient research context, and verification guidance.
-
Exton, PA, March 06, 2026 (GLOBE NEWSWIRE) -- New findings from Spherix Global Insights’ Patient Chart Dynamix™: Lupus Nephritis (US), 2025 report reveal a treatment landscape in transition as...
-
ISELIN, N.J., March 05, 2026 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of...
-
Exton, PA, March 05, 2026 (GLOBE NEWSWIRE) -- Spherix Global Insights today announces the release of its latest Market Dynamix™: Paroxysmal Nocturnal Hemoglobinuria (PNH) (US) 2026 study, revealing...
-
Exton, PA, March 05, 2026 (GLOBE NEWSWIRE) -- Spherix Global Insights today announces the release of its latest Market Dynamix™: Paroxysmal Nocturnal Hemoglobinuria (PNH) (US) 2026 study, revealing...